Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-15 · accession 0001062993-22-022243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-16 | 2022-11-15 | CGTX | Ricciardi Lisa | CEO, Pres, Dir | P - Purchase | $1.30 | +12.0K | 24.5K | +96% | +$15.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-15 | P | A | 12,000 | $1.30 | 24,500 | D | — | — | (F1) Represents the weighted average purchase price of $1.297. These shares were acquired in multiple transactions ranging from $1.285 to $1.300 rounded to the nearest thousandth. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission, Cognition Therapeutics, Inc. (the "Issuer"), or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |